Researchers at LUMC have made a breakthrough in understanding PALB2 mutations, an important cause of hereditary breast cancer ...
A new study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...
Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...
Experimental gene therapies like AMT‑130 lower toxic huntingtin protein and significantly slow Huntington’s disease, offering ...
New study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...
On behalf of Lilly, Seamless will design and programme recombinases that can correct alterations in multiple genes involved ...
Eli Lilly signed an agreement worth up to $1.12 billion with Seamless Therapeutics, ​the Germany-based startup said on ...
Alcohol can harm more than your liver and heart—new insights reveal it damages DNA, increasing cancer risk. Experts explain ...
Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...